Page last updated: 2024-12-06
trifluoromethanesulfonanilide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 68012 |
CHEMBL ID | 286402 |
SCHEMBL ID | 216185 |
MeSH ID | M0102348 |
Synonyms (39)
Synonym |
---|
HMS1784H08 |
456-64-4 |
methanesulfonanilide, 1,1,1-trifluoro- |
brn 2214142 |
n-phenyltriflamide |
n-phenyl-1,1,1-trifluoromethanesulfonamide |
trifluoromethanesulfonanilide |
methanesulfonamide, n-phenyl-1,1,1-trifluoro- |
CHEMBL286402 |
1,1,1-trifluoro-n-phenylmethanesulfonamide |
AKOS003622726 |
4-12-00-01061 (beilstein handbook reference) |
n-phenyltrifluoromethanesulfonamide |
1,1,1-trifluoromethanesulfonanilide |
phenyltriflamide |
SCHEMBL216185 |
AM80898 |
methanesulfonamide, 1,1,1-trifluoro-n-phenyl- |
T2985 |
n-phenyltrifluoromethane sulphonamide |
n-phenyl trifluoromethanesulfonamide |
n-phenyltrifluoromethane-sulfonamide |
phnhtf |
phenyl triflamide |
c,c,c-trifluoro-n-phenylmethanesulfonamide |
n-phenyltrifluoromethane sulfonamide |
n-phenyltrifluoro-methanesulfonamide |
n-phenyl(trifluoromethanesulfonamide) |
FD13132 |
n-phenyl(trifluoromethane)sulfonamide |
mfcd00521820 |
DTXSID20196570 |
DS-8107 |
BB 0304059 |
SB79856 |
CS-0156098 |
n-[(trifluoromethyl)sulfonyl]aniline |
SY027422 |
EN300-117227 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (4)
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.30
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.30) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |